Prasad Raju — SEC Form 4 filings
SEC reporting owner CIK 1968317. 14 Form 4 filings on record with FilingPulse; latest filed 2026-08-11.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-03-18 to 2026-08-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 8 filings — 97,732 shares, $5,604,881 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 31.
- Largest priced transaction: sale of 34,972 shares @ $60.19 ($2,104,965) in CRISPR Therapeutics AG, filed 2026-01-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | 14 | — | 13 legs · 97,732 sh · $5,604,881 | 31 |
Form 4 filings — Prasad Raju
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-11 | 4 | CRISPR Therapeutics AG (CRSP) | Gift (G): 750 @ $0 | EDGAR |
| 2026-06-02 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 19,500 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 6,250 · Sale (S): 3,708 @ $46.78 · Grant/award (A): 38,499 (derivative) @ $0 · Grant/award (A): 27,500 (derivative) @ $0 · Option exercise (M): 6,250 (derivative) | EDGAR |
| 2026-03-17 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 10,000 · Option exercise (M): 6,875 · Sale (S): 5,848 @ $48.26 · Sale (S): 4,021 @ $48.26 · Gift (G): 750 @ $0 · Option exercise (M): 10,000 (derivative) · +1 more | EDGAR |
| 2026-01-26 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 34,972 @ $45.15 · Sale (S): 34,972 @ $60.19 · Option exercise (M): 34,972 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 23,361 @ $45.15 · Option exercise (M): 6,339 @ $44.31 · Sale (S): 18,933 @ $60.18 · Sale (S): 5,004 @ $60 · Sale (S): 5,763 @ $60.21 · Option exercise (M): 23,361 (derivative) @ $0 · +1 more | EDGAR |
| 2025-12-23 | 4 | CRISPR Therapeutics AG (CRSP) | Sale (S): 3,528 @ $55.10 · Sale (S): 5,472 @ $56.33 · Sale (S): 1,000 @ $56.89 | EDGAR |
| 2025-10-03 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 6,250 · Sale (S): 2,197 @ $41.23 · Option exercise (M): 6,250 (derivative) | EDGAR |
| 2025-03-18 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 10,000 · Sale (S): 3,762 @ $41.80 · Option exercise (M): 10,000 (derivative) · Grant/award (A): 36,666 (derivative) @ $0 · Grant/award (A): 27,500 (derivative) @ $0 | EDGAR |
| 2024-10-18 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 18,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-03-22 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 36,168 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-03-18 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 10,000 · Sale (S): 3,524 @ $72.69 · Option exercise (M): 10,000 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1968317 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →